|
Market Closed -
Euronext Paris
11:55:00 2026-08-17 EDT
|
5-day change | 1st Jan Change | ||
| 0.7260 EUR | +0.83% |
|
+0.55% | -24.38% |
Company Valuation: Transgene
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 247.8 | 164.8 | 137.8 | 89.75 | 262.9 | 198.8 | - | - |
| Change | - | -33.52% | -16.38% | -34.86% | 192.89% | -24.36% | - | - |
| Enterprise Value (EV) 1 | 214.9 | 151.4 | 139.4 | 83.48 | 153.1 | 129.6 | 191.1 | 217.4 |
| Change | - | -29.53% | -7.95% | -40.12% | 83.37% | -15.31% | 47.44% | 13.76% |
| P/E | -12.1x | -5.02x | -6.23x | -2.34x | -3.69x | -5.19x | -3.3x | -8.07x |
| PBR | 3.69x | 4.38x | 8.82x | 5.92x | 1.14x | 2.42x | 9.08x | -72.6x |
| PEG | - | -0.1x | 0.2x | -0.1x | 0.4x | 0.1x | -0.1x | 0.1x |
| Capitalization / Revenue | 14.2x | 15.9x | 17.4x | 14.1x | 36.5x | 27.6x | 27.6x | 3.48x |
| EV / Revenue | 12.3x | 14.6x | 17.6x | 13.1x | 21.2x | 18x | 26.5x | 3.8x |
| EV / EBITDA | -10.2x | -5.37x | -4.9x | -2.43x | -4.54x | -2.97x | -2.73x | -9.21x |
| EV / EBIT | -9.14x | -5.06x | -4.64x | -2.34x | -4.37x | -2.93x | -2.7x | -7.42x |
| EV / FCF | -6.59x | -6.94x | -1,408x | -3.12x | -1.07x | -3.27x | -3.16x | -8.66x |
| FCF Yield | -15.2% | -14.4% | -0.07% | -32% | -93.4% | -30.6% | -31.6% | -11.5% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.21 | -0.33 | -0.22 | -0.29 | -0.26 | -0.14 | -0.22 | -0.09 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 17.41 | 10.34 | 7.9 | 6.353 | 7.21 | 7.2 | 7.2 | 57.2 |
| EBITDA 1 | -21 | -28.22 | -28.48 | -34.38 | -33.73 | -43.6 | -70.1 | -23.6 |
| EBIT 1 | -23.52 | -29.9 | -30.05 | -35.66 | -35.06 | -44.3 | -70.8 | -29.3 |
| Net income 1 | -19.54 | -32.8 | -22.33 | -33.97 | -37.52 | -38.2 | -61.6 | -25.3 |
| Net Debt 1 | -32.93 | -13.31 | 1.629 | -6.274 | -109.8 | -69.2 | -7.7 | 18.6 |
| Reference price 2 | 2.5400 | 1.6580 | 1.3700 | 0.6800 | 0.9600 | 0.7260 | 0.7260 | 0.7260 |
| Nbr of stocks (in thousands) | 97,576 | 99,370 | 100,566 | 131,990 | 273,827 | 273,882 | - | - |
| Announcement Date | 3/16/22 | 3/16/23 | 3/27/24 | 3/27/25 | 3/24/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.14x | 17.78x | -2.94x | - | 228M | |
| 20.97x | 7.34x | 14.96x | 1.41% | 70.07B | |
| 30.34x | 7.64x | 23.38x | 0.05% | 52.87B | |
| -78.21x | 14.61x | -74.55x | -.--% | 27.02B | |
| 29.96x | 5.86x | 15.52x | -.--% | 23.61B | |
| -14.6x | 5.15x | -6.71x | -.--% | 23.38B | |
| 56.69x | 21.05x | 42.62x | 0.06% | 19.43B | |
| 25.59x | 4.85x | 16.27x | -.--% | 18.75B | |
| -802.92x | 37.67x | -14929.22x | -.--% | 15.85B | |
| 15.89x | 4.68x | 10.93x | -.--% | 12.7B | |
| Average | -72.14x | 12.66x | -1,488.98x | 0.17% | 26.39B | |
| Weighted average by Cap. | -36.46x | 10.35x | -890.21x | 0.39% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- TNG Stock
- Valuation Transgene
Select your edition
All financial news and data tailored to specific country editions
